James Huang - Aug 24, 2022 Form 4 Insider Report for CASI Pharmaceuticals, Inc. (CASI)

Role
Director
Signature
/s/ James Huang
Stock symbol
CASI
Transactions as of
Aug 24, 2022
Transactions value $
$166,930
Form type
4
Date filed
8/26/2022, 08:48 PM
Previous filing
Aug 23, 2022
Next filing
Sep 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CASI Common Stock Purchase $18.8K +5K +2.13% $3.75* 239K Aug 24, 2022 See Footnote F1
transaction CASI Common Stock Purchase $148K +39.5K +16.52% $3.75* 279K Aug 26, 2022 See footnote F1, F2
holding CASI Common Stock 191 Aug 24, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities held by Panacea Opportunity Fund I, L.P., over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.
F2 The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.70 to $3.75. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.